Inventiva IVA
NASDAQ IVA
$3.56 +0.10 (+2.89%)
At close: Oct 2, 2026 · 4:00 PM EDT

Inventiva (IVA) Return on Sales [ROS] (2020 - 2021)

Updated

Inventiva's Return on Sales [ROS] came in at -3145.51% for FY2025, down 2084.86 percentage points from -1060.64% in FY2024.

Analysis

Inventiva (IVA) Return on Sales [ROS] (2020 - 2021) Analysis & Trends

Going back to FY2018, Inventiva's Return on Sales [ROS] data covers 8 years.

  • Return on Sales [ROS] has declined in each of the last three years, though with a five-year change of +4843.20 percentage points (FY2020 to FY2025).
  • The FY2025 figure represents the lowest annual Return on Sales [ROS] since FY2020.
  • Per Business Quant, earlier years put Return on Sales [ROS] at -1060.64% in FY2024 (-472.96 pp), -587.68% in FY2023 (-118.76 pp), -468.92% in FY2022 (+773.66 pp) and -1242.58% in FY2021 (+6746.13 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 28.21%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 37.86%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 32.97%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 20.57%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 34.95%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -133.21%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 28.37%
10 Inventiva 687.92 Mn 687.92 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 -21,021.54%
Mar 31, 2021 -13,435.14%
Jun 30, 2020 -11,972.97%
Mar 31, 2020 -7,821.84%
API Access

Inventiva Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=IVA&period=max&api_key=YOUR_API_KEY